Imperial Brand's Development Strategy for Dual Markets

Sep.26.2022
Imperial Brand's Development Strategy for Dual Markets
Imperial Brands focuses on two markets: traditional tobacco and next-generation products. They prioritize the US, UK, and Australia.

The current development strategy of Empire Brand is to balance two markets: on one hand, to focus on the combustible tobacco product market and further enhance the market value of its product portfolio; on the other hand, to continuously explore new types of tobacco products (referred to as next-generation products by Empire Brand) in the market.


Imperial Brands concentrates its resources on the US, Germany, UK, Australia and Spanish markets, with 72% of its revenue from combustible tobacco products derived from these markets. Last year, the company saw an increase in sales in the US, UK and Australia markets, while experiencing a decline in sales in Germany and Spain. The increased market share was achieved while maintaining stable prices. Imperial Brands is intensifying its efforts in these markets to further increase its share of the market.


To further enhance profitability, the Empire brand selectively cultivates markets with potential for growth, such as Africa and Europe, while also selectively exiting markets where their business is relatively weak.


Expanding its business in new tobacco products while maintaining a stronghold in the combustible tobacco market is a crucial part of the Empire Brand's strategy for promoting sustainability. In the European market, heated tobacco is the primary category of new tobacco products. The Empire Brand believes that its advantage in the traditional tobacco market can assist in the development of new tobacco products.


Empire brand focuses on heating combustible cigarettes in the European market and on electronic cigarettes in the American market. At the same time, the brand's oral tobacco business remains focused on the European market.


Imperial Brands has launched its heated tobacco product, Pulze, in the Czech and Greek markets. Currently, heated tobacco products make up approximately 10% of the tobacco market share in the Czech Republic and over 10% in Greece, with further potential for growth in these two countries.


The empire brand has revamped its marketing strategy for the Blu e-cigarette sold in the United States in order to further increase sales.


In March of this year, Imperial Brands launched an awareness campaign for their electronic cigarette products in Canada. The aim was to educate Canadian consumers on the differences between e-cigarettes and traditional tobacco products. The company invested heavily in outdoor and digital advertising to increase product visibility. The campaign lasted for 10 weeks and was just one part of Imperial Brands' broader marketing efforts.


The Empire brand stated that their strategic goal is to establish a sustainable, consumer-centered next-generation product business system and they are currently making good progress towards this aim.


Stefan Bommhardt, CEO of the Imperial brand, stated, "We have conducted a comprehensive review of our business development strategy, searching for all possible opportunities that can bring value. Our five-year plan outlines our priorities that will determine our investment targets for the market and the brand. We will improve our working methods and create a flexible, collaborative, performance-based operating model to achieve better and more stable business performance.


Empire brand has identified three key factors to drive its development strategy: customer-centric approach, performance-based operational model, and streamlined and efficient processes. To support this strategy, the company has decided to increase investment in core business departments such as marketing by £50-60 million per year. Additionally, with business restructuring and simplification, Empire brand expects to save £100-150 million in costs by the end of fiscal year 2023.


This article contains excerpts or reprints from third-party sources, and their copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any units or individuals wishing to reprint should contact the author and refrain from directly copying.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06